FDA Adverse Event Injury Summary report: N

OPTEASE VENA CAVA FILTER

MDR report key: 1111741 · Received August 12, 2008

Report

Report Number
9610978-2008-00206
Event Type
Injury
Date Received
August 12, 2008
Date of Event
July 11, 2008
Report Date
July 16, 2008
Manufacturer
CORDIS EUROPA, N.V.
Product Code
DTK
PMA / PMN Number
K034050
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NH, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT IS NOT AVAILABLE FOR ANALYSIS. ADD'L INFO WILL BE SUBMITTED WITHIN THIRTY DAYS UPON RECEIPT.

Description of Event or Problem · 1

THE MALE PT RECEIVED AN OPTEASE RETRIEVABLE FILTER. THE PT HAD SEVERE SWELLING FROM THE WAIST DOWN 2 DAYS AFTER THE OPTEASE WAS IMPLANTED. VENEGRAM WAS PERFORMED AND ACUTE THROMBOSIS WAS DISCOVERED IN THE OPTEASE RETRIEVABLE FILTER. THROMBOLYSIS WAS PERFORMED ON BOTH LEGS AND THE CLOT WAS ANGIOJETTED OUT OF BOTH LEGS. THEY WERE ABLE TO REMOVE THE OPTEASE FILTER. THE PT IS DOING WELL, HOWEVER STILL HAS SWELLING OF THE SCROTUM AND PENIS. PER THE SALES REP ANGIO SHOWED NARROWING OF ILIAC VEINS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 OPTEASE VENA CAVA FILTER THROMBECTOMY SYSTEMS (DTK) DTK CORDIS EUROPA, N.V. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 67 YR Required Intervention